| ABTS | 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) |
| Ac | Acetyl |
| ADME(T) | Absorption, distribution, metabolism, excretion, (toxicity) |
| AKT | Protein kinase B |
| ATR | Attenuated total reflectance |
| CB | Cannabinoid receptor |
| CBD | Cannabidiol |
| D | Dimension |
| DCM | Dichloromethane |
| DPI | Dots per inch |
| DPPH | 2,2-Diphenyl-1-picrylhydrazyl |
| Ent | Enantiomer |
| Et | Ethyl |
| FT-IR | Fourier transform infrared |
| GI | Gastrointestinal |
| HF-DFT | Hartree-Fock density functional theory |
| HL | Human leukemia cell line |
| IBD | Inflammatory bowel disease |
| ID | Identification code |
| IL | Interleukin cytokine |
| LHMDS | Lithium hexamethyldisilazane |
| LNCaP | Lymph node carcinoma of the prostate cell line |
| LPS | Lipopolysaccharide |
| MGL | Molecular graphics laboratory |
| MITF | Microphthalmia-associated transcription factor |
| MM | Molecular mechanics |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| mTOR | Mechanistic target of rapamycin |
| MW | Molecular weight |
| N/A | Not available |
| NF-κB | Nuclear factor kappa B |
| NMR | Nuclear magnetic resonance |
| ORAC | Oxygen radical absorbance capacity |
| P-gp | P-glycoprotein |
| PC | Prostate cancer cell line |
| PDB | Protein data bank |
| PDBQT | Protein data bank + partial charge (Q) + atom type (T) |
| PEO | Peppermint essential oil |
| Ph | Phenyl |
| ppm | Parts per million |
| RCSB | Research collaboratory for structural bioinformatics |
| SCF | Secure controls framework |
| SMILES | Simplified molecular input line entry system |
| Tf | Trifluoromethanesulfonyl |
| THC | Δ9-Tetrahydrocannabinol |
| THCBD | Tetrahydrocannabidiol |
| THF | Tetrahydrofuran |
| TLC | Thin layer chromatography |
| TNF-α | Tumor necrosis factor-alpha |
| TPSA | Topological polar surface area |
| TRPA | Transient receptor potential ankyrin channel |
| TRPM | Transient receptor potential melastatin channel |
| TRPV | Transient receptor potential vanilloid channel |
| UV | Ultraviolet |
| VDW | Van der Waals interactions |
| VLA | Very late activation antigen |
| VRE | Vancomycin-resistant enterococcus |